NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 248 filers reported holding NEOGENOMICS INC in Q3 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $596,120 | -23.5% | 48,465 | 0.0% | 0.25% | -18.2% |
Q2 2023 | $778,833 | -7.7% | 48,465 | 0.0% | 0.30% | -13.5% |
Q1 2023 | $843,776 | +88.4% | 48,465 | 0.0% | 0.35% | +80.8% |
Q4 2022 | $447,817 | +7.4% | 48,465 | 0.0% | 0.19% | +2.7% |
Q3 2022 | $417,000 | +5.6% | 48,465 | 0.0% | 0.19% | +11.2% |
Q2 2022 | $395,000 | -31.9% | 48,465 | +1.6% | 0.17% | -17.6% |
Q1 2022 | $580,000 | -64.4% | 47,700 | 0.0% | 0.20% | -61.7% |
Q4 2021 | $1,627,000 | -35.3% | 47,700 | -8.4% | 0.54% | -37.0% |
Q3 2021 | $2,513,000 | +6.8% | 52,100 | 0.0% | 0.85% | +10.3% |
Q2 2021 | $2,353,000 | -45.9% | 52,100 | -42.2% | 0.77% | -51.0% |
Q1 2021 | $4,350,000 | -82.3% | 90,200 | -80.3% | 1.57% | -19.2% |
Q4 2020 | $24,630,000 | +45.4% | 457,500 | -0.3% | 1.94% | +8.2% |
Q3 2020 | $16,935,000 | +18.8% | 459,000 | -0.2% | 1.80% | +13.5% |
Q2 2020 | $14,250,000 | +461.0% | 460,000 | +400.0% | 1.58% | -15.3% |
Q1 2020 | $2,540,000 | -18.5% | 92,000 | -13.6% | 1.87% | +18.0% |
Q4 2019 | $3,115,000 | +44.8% | 106,500 | -5.3% | 1.58% | +44.9% |
Q3 2019 | $2,151,000 | -13.5% | 112,500 | -0.7% | 1.09% | -11.8% |
Q2 2019 | $2,486,000 | +2.1% | 113,300 | -4.8% | 1.24% | +1.1% |
Q1 2019 | $2,435,000 | +44.6% | 119,000 | -10.9% | 1.23% | +26.1% |
Q4 2018 | $1,684,000 | -88.8% | 133,550 | -86.4% | 0.97% | -30.1% |
Q3 2018 | $15,080,000 | +16.4% | 982,465 | -0.6% | 1.39% | +15.7% |
Q2 2018 | $12,955,000 | +544.2% | 988,165 | +300.9% | 1.20% | +20.0% |
Q1 2018 | $2,011,000 | -10.5% | 246,483 | -2.8% | 1.00% | -7.0% |
Q4 2017 | $2,246,000 | -21.4% | 253,483 | -1.2% | 1.08% | -19.0% |
Q3 2017 | $2,856,000 | +20.2% | 256,623 | -3.2% | 1.33% | +23.4% |
Q2 2017 | $2,376,000 | -77.4% | 265,223 | -80.1% | 1.08% | +10.5% |
Q1 2017 | $10,505,000 | +324.3% | 1,331,615 | +360.9% | 0.98% | -15.1% |
Q4 2016 | $2,476,000 | +2.8% | 288,923 | -1.4% | 1.15% | -2.1% |
Q3 2016 | $2,408,000 | +1.5% | 292,923 | -0.7% | 1.18% | -6.4% |
Q2 2016 | $2,372,000 | +10.2% | 295,003 | -7.6% | 1.26% | +1.3% |
Q1 2016 | $2,153,000 | -15.6% | 319,423 | -1.4% | 1.24% | -17.6% |
Q4 2015 | $2,550,000 | +0.7% | 324,023 | -26.7% | 1.50% | +3.2% |
Q3 2015 | $2,532,000 | +1.4% | 441,950 | -4.2% | 1.46% | +17.8% |
Q2 2015 | $2,496,000 | +10.2% | 461,450 | -4.8% | 1.24% | +14.0% |
Q1 2015 | $2,264,000 | +10.5% | 484,900 | -1.3% | 1.09% | +13.5% |
Q4 2014 | $2,048,000 | -20.1% | 491,100 | -0.2% | 0.96% | -20.2% |
Q3 2014 | $2,564,000 | +54.2% | 492,100 | -1.8% | 1.20% | +82.4% |
Q2 2014 | $1,663,000 | -6.3% | 500,900 | -2.0% | 0.66% | -12.3% |
Q1 2014 | $1,774,000 | -7.1% | 511,100 | -2.1% | 0.75% | -5.5% |
Q4 2013 | $1,909,000 | +19.7% | 522,000 | -1.8% | 0.79% | +12.5% |
Q3 2013 | $1,595,000 | -25.5% | 531,700 | -1.1% | 0.71% | -29.5% |
Q2 2013 | $2,140,000 | – | 537,700 | – | 1.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |